-
UNITED THERAPEUTICS CORPORATION v. SANDOZ, INC. et al DC CAFC
- 3:13-cv-00316
- D.N.J.
- Judge: Peter G. Sheridan +1
- Filed: 01/16/2013
- Closed: 08/29/2014
- Latest Docket Entry: 01/12/2016
- PACER
- Docket updated daily
1
Plaintiff
1
Defendant
0
Accused
Products
3
Patents-in-Suit
591
Days in
Litigation
-
UNITED THERAPEUTICS CORPORATION v. SANDOZ, INC. et al DC CAFC
- 3:13-cv-00316
- D.N.J.
- Judge: Peter G. Sheridan +1
- Filed: 01/16/2013
- Closed: 08/29/2014
- Latest Docket Entry: 01/12/2016
- PACER
- Docket updated daily
Complaint Unavailable
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim | Outcome |
---|---|
All challenged claims |
Valid (102 and 103)
Entry 162 |
-
Infringement
Sandoz Inc.
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
NATreprostinil sodium injection | US 6,765,117 B2 | All Asserted Claims |
Infringement
Entry 161Entry 162 |
NATreprostinil sodium injection | US 7,999,007 B2 | All Asserted Claims |
Infringement
Entry 161Entry 162 |